GLAXOSMITHKLINE FDA Approval ANDA 062270

ANDA 062270

GLAXOSMITHKLINE

FDA Drug Application

Application #062270

Application Sponsors

ANDA 062270GLAXOSMITHKLINE

Marketing Status

Discontinued001
Discontinued002

Application Products

001FOR SOLUTION;ORALEQ 125MG BASE/5ML0BEEPEN-VKPENICILLIN V POTASSIUM
002FOR SOLUTION;ORALEQ 250MG BASE/5ML0BEEPEN-VKPENICILLIN V POTASSIUM

FDA Submissions

ORIG1AP1980-08-15
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1989-02-06
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1991-02-22
LABELING; LabelingSUPPL8AP1995-05-08
LABELING; LabelingSUPPL9AP1996-03-06
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1998-04-20

Submissions Property Types

ORIG1Null0
SUPPL5Null0
SUPPL6Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0

CDER Filings

GLAXOSMITHKLINE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62270
            [companyName] => GLAXOSMITHKLINE
            [docInserts] => ["",""]
            [products] => [{"drugName":"BEEPEN-VK","activeIngredients":"PENICILLIN V POTASSIUM","strength":"EQ 125MG BASE\/5ML","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"BEEPEN-VK","activeIngredients":"PENICILLIN V POTASSIUM","strength":"EQ 250MG BASE\/5ML","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"BEEPEN-VK","submission":"PENICILLIN V POTASSIUM","actionType":"EQ 125MG BASE\/5ML","submissionClassification":"FOR SOLUTION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"BEEPEN-VK","submission":"PENICILLIN V POTASSIUM","actionType":"EQ 250MG BASE\/5ML","submissionClassification":"FOR SOLUTION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.